vs
Side-by-side financial comparison of TSS, Inc. (TSSI) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
TSS, Inc. is the larger business by last-quarter revenue ($60.9M vs $57.2M, roughly 1.1× Vanda Pharmaceuticals Inc.). TSS, Inc. runs the higher net margin — 20.0% vs -246.8%, a 266.7% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs 7.6%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $-29.5M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 9.8%).
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
TSSI vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.9M | $57.2M |
| Net Profit | $12.2M | $-141.2M |
| Gross Margin | 17.6% | — |
| Operating Margin | 1.5% | -70.5% |
| Net Margin | 20.0% | -246.8% |
| Revenue YoY | 21.8% | 7.6% |
| Net Profit YoY | 535.7% | -2774.3% |
| EPS (diluted) | $0.44 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $60.9M | $57.2M | ||
| Q3 25 | $41.9M | $56.3M | ||
| Q2 25 | $44.0M | $52.6M | ||
| Q1 25 | $99.0M | $50.0M | ||
| Q4 24 | $50.0M | $53.2M | ||
| Q3 24 | $70.1M | $47.7M | ||
| Q2 24 | $12.2M | $50.5M | ||
| Q1 24 | $15.9M | $47.5M |
| Q4 25 | $12.2M | $-141.2M | ||
| Q3 25 | $-1.5M | $-22.6M | ||
| Q2 25 | $1.5M | $-27.2M | ||
| Q1 25 | $3.0M | $-29.5M | ||
| Q4 24 | $1.9M | $-4.9M | ||
| Q3 24 | $2.6M | $-5.3M | ||
| Q2 24 | $1.4M | $-4.5M | ||
| Q1 24 | $15.0K | $-4.1M |
| Q4 25 | 17.6% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 11.3% | — | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 17.1% | — |
| Q4 25 | 1.5% | -70.5% | ||
| Q3 25 | -2.2% | -55.6% | ||
| Q2 25 | 5.1% | -73.2% | ||
| Q1 25 | 4.2% | -82.0% | ||
| Q4 24 | 0.0% | -19.3% | ||
| Q3 24 | 5.4% | -23.1% | ||
| Q2 24 | 14.0% | -20.1% | ||
| Q1 24 | 1.6% | -19.5% |
| Q4 25 | 20.0% | -246.8% | ||
| Q3 25 | -3.6% | -40.1% | ||
| Q2 25 | 3.4% | -51.7% | ||
| Q1 25 | 3.0% | -58.9% | ||
| Q4 24 | 3.8% | -9.2% | ||
| Q3 24 | 3.8% | -11.2% | ||
| Q2 24 | 11.5% | -9.0% | ||
| Q1 24 | 0.1% | -8.7% |
| Q4 25 | $0.44 | $-2.40 | ||
| Q3 25 | $-0.06 | $-0.38 | ||
| Q2 25 | $0.06 | $-0.46 | ||
| Q1 25 | $0.12 | $-0.50 | ||
| Q4 24 | $0.08 | $-0.09 | ||
| Q3 24 | $0.10 | $-0.09 | ||
| Q2 24 | $0.06 | $-0.08 | ||
| Q1 24 | $0.00 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $85.5M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $76.6M | $327.2M |
| Total Assets | $184.9M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $85.5M | $84.9M | ||
| Q3 25 | $70.7M | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | $23.2M | $102.3M | ||
| Q3 24 | $46.4M | $100.5M | ||
| Q2 24 | $8.3M | $103.0M | ||
| Q1 24 | $14.4M | $125.2M |
| Q4 25 | $76.6M | $327.2M | ||
| Q3 25 | $63.4M | $466.0M | ||
| Q2 25 | $9.5M | $486.3M | ||
| Q1 25 | $9.4M | $511.4M | ||
| Q4 24 | $7.1M | $538.5M | ||
| Q3 24 | $7.7M | $541.2M | ||
| Q2 24 | $5.2M | $542.5M | ||
| Q1 24 | $3.7M | $544.0M |
| Q4 25 | $184.9M | $488.9M | ||
| Q3 25 | $165.4M | $601.1M | ||
| Q2 25 | $139.5M | $624.7M | ||
| Q1 25 | $113.5M | $631.9M | ||
| Q4 24 | $96.6M | $656.2M | ||
| Q3 24 | $67.3M | $645.1M | ||
| Q2 24 | $28.9M | $651.4M | ||
| Q1 24 | $26.8M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $-29.4M |
| Free Cash FlowOCF − Capex | $15.8M | $-29.5M |
| FCF MarginFCF / Revenue | 25.9% | -51.6% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $-29.4M | ||
| Q3 25 | $-18.4M | $-31.6M | ||
| Q2 25 | $16.3M | $-15.3M | ||
| Q1 25 | $20.6M | $-33.1M | ||
| Q4 24 | $-21.6M | $-1.8M | ||
| Q3 24 | $38.6M | $-14.6M | ||
| Q2 24 | $-4.3M | $-6.9M | ||
| Q1 24 | $2.6M | $7.6M |
| Q4 25 | $15.8M | $-29.5M | ||
| Q3 25 | $-24.9M | $-31.8M | ||
| Q2 25 | $5.4M | $-15.6M | ||
| Q1 25 | $5.8M | $-33.6M | ||
| Q4 24 | $-28.4M | $-2.0M | ||
| Q3 24 | $38.6M | $-14.7M | ||
| Q2 24 | $-6.0M | $-7.0M | ||
| Q1 24 | $2.6M | $7.6M |
| Q4 25 | 25.9% | -51.6% | ||
| Q3 25 | -59.3% | -56.5% | ||
| Q2 25 | 12.3% | -29.6% | ||
| Q1 25 | 5.8% | -67.1% | ||
| Q4 24 | -56.7% | -3.8% | ||
| Q3 24 | 55.1% | -30.9% | ||
| Q2 24 | -49.4% | -13.9% | ||
| Q1 24 | 16.4% | 15.9% |
| Q4 25 | 0.9% | 0.2% | ||
| Q3 25 | 15.3% | 0.3% | ||
| Q2 25 | 24.8% | 0.6% | ||
| Q1 25 | 15.0% | 0.9% | ||
| Q4 24 | 13.4% | 0.4% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 13.8% | 0.2% | ||
| Q1 24 | 0.2% | 0.0% |
| Q4 25 | 1.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.02× | — | ||
| Q1 25 | 6.93× | — | ||
| Q4 24 | -11.32× | — | ||
| Q3 24 | 14.60× | — | ||
| Q2 24 | -3.09× | — | ||
| Q1 24 | 176.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
